Carmen Bozic, the EVP and CMO of $VRTX, sold 2,329 shares of the company on 02-27-2026 for an estimated $1,118,641. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.8% of their shares of this class of stock. Following this trade, they now own 37,734 shares of this class of $VRTX stock.
$VRTX Insider Trading Activity
$VRTX insiders have traded $VRTX stock on the open market 59 times in the past 6 months. Of those trades, 0 have been purchases and 59 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by insiders over the last 6 months:
- JEFFREY M LEIDEN (Executive Chairman) has made 0 purchases and 17 sales selling 137,073 shares for an estimated $60,942,656.
- AMIT SACHDEV (EVP Chief Patient & Ext Af Off) has made 0 purchases and 9 sales selling 60,459 shares for an estimated $28,377,385.
- CHARLES F JR WAGNER (EVP, CO & FO) has made 0 purchases and 3 sales selling 23,532 shares for an estimated $10,778,252.
- OURANIA TATSIS (EVP, Chief Reg. & Quality Off.) has made 0 purchases and 7 sales selling 12,203 shares for an estimated $5,725,801.
- JONATHAN BILLER (EVP and Chief Legal Officer) has made 0 purchases and 7 sales selling 8,619 shares for an estimated $4,076,426.
- EDWARD MORROW III ATKINSON (EVP, Chief Technical Ops. Off.) has made 0 purchases and 5 sales selling 7,767 shares for an estimated $3,598,634.
- MARK E. BUNNAGE (EVP, Chief Scientific Officer) has made 0 purchases and 4 sales selling 6,260 shares for an estimated $2,984,769.
- DUNCAN MCKECHNIE (EVP, Chief Commercial Officer) has made 0 purchases and 2 sales selling 4,910 shares for an estimated $2,394,365.
- CARMEN BOZIC (EVP and CMO) sold 2,329 shares for an estimated $1,118,641
- KRISTEN AMBROSE (SVP & Chief Accounting Officer) has made 0 purchases and 3 sales selling 1,956 shares for an estimated $914,567.
- SANGEETA N. BHATIA sold 266 shares for an estimated $133,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRTX Hedge Fund Activity
We have seen 794 institutional investors add shares of $VRTX stock to their portfolio, and 774 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,547,690 shares (-74.0%) from their portfolio in Q4 2025, for an estimated $3,875,180,738
- PARNASSUS INVESTMENTS, LLC removed 1,648,433 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $747,333,584
- BLACKROCK, INC. added 1,498,942 shares (+6.7%) to their portfolio in Q4 2025, for an estimated $679,560,345
- VICTORY CAPITAL MANAGEMENT INC added 1,109,200 shares (+49.4%) to their portfolio in Q4 2025, for an estimated $502,866,912
- FMR LLC removed 1,091,172 shares (-33.0%) from their portfolio in Q4 2025, for an estimated $494,693,737
- WELLINGTON MANAGEMENT GROUP LLP removed 950,311 shares (-19.9%) from their portfolio in Q4 2025, for an estimated $430,832,994
- WINSLOW CAPITAL MANAGEMENT, LLC added 887,640 shares (+inf%) to their portfolio in Q4 2025, for an estimated $402,420,470
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VRTX Revenue
$VRTX had revenues of $3.2B in Q4 2025. This is an increase of 9.55% from the same period in the prior year.
You can track VRTX financials on Quiver Quantitative's VRTX stock page.
$VRTX Congressional Stock Trading
Members of Congress have traded $VRTX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR sold up to $15,000 on 01/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$VRTX Analyst Ratings
Wall Street analysts have issued reports on $VRTX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 02/13/2026
- Bernstein issued a "Outperform" rating on 01/12/2026
- Leerink Partners issued a "Outperform" rating on 12/29/2025
- Wells Fargo issued a "Overweight" rating on 12/10/2025
- UBS issued a "Buy" rating on 11/07/2025
- Citigroup issued a "Buy" rating on 10/02/2025
- Evercore ISI Group issued a "Outperform" rating on 09/11/2025
To track analyst ratings and price targets for $VRTX, check out Quiver Quantitative's $VRTX forecast page.
$VRTX Price Targets
Multiple analysts have issued price targets for $VRTX recently. We have seen 17 analysts offer price targets for $VRTX in the last 6 months, with a median target of $541.0.
Here are some recent targets:
- Eliana Merle from Barclays set a target price of $607.0 on 02/17/2026
- Whitney Ijem from Canaccord Genuity set a target price of $441.0 on 02/17/2026
- Andrew S. Fein from HC Wainwright & Co. set a target price of $591.0 on 02/17/2026
- Jay Olson from Oppenheimer set a target price of $540.0 on 02/13/2026
- Paul Matteis from Stifel set a target price of $466.0 on 02/13/2026
- Greg Harrison from Scotiabank set a target price of $558.0 on 02/13/2026
- Brian Abrahams from RBC Capital set a target price of $541.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
